EVGN - Evogene
Evogene Logo

EVGN - Evogene

https://www.evogene.com
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Downtrend
Source: Snapshot

Evogene Ltd., is a computational biology company. The company is headquartered in Rehovot, Israel.

52W High
$3.32
52W Low
$0.95
MA Status:
50D: Below 200D: Below
Beta (~1 neutral, <0.9 lower risk)
1.42
Valuation
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
-0.81
EV/Revenue (<3 favorable)
1.25
P/S (TTM) (<3 favorable)
1.15
P/B (<3 favorable)
4.71
Ownership
Retail‑heavy
Source: Overview
Insiders (1–5% typical)
0.96%
Institutions (25–75% balanced)
1.61%
Shares Outstanding
8,714,200
Float
7,154,600
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
9,444,000
Gross Profit (TTM)
5,754,000
EPS (TTM)
-1.97
Profit Margin (>10% good)
-1.51%
Operating Margin (TTM) (higher better)
-3.47%
ROE (TTM) (>15% strong)
-0.98%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
-0.03
Momentum
Value
N/A
Previous
N/A
Trend
—
Signal Cross
No cross
As of
—